跳至主要内容
临床试验/NCT05230394
NCT05230394暂停不适用

Randomized Control Trial to Compare Patient Outcomes Following Unattended Polysomnography Versus In-lab Polysomnography for Sleep Apnea and Comorbid Sleep Disorders

Cerebra Medical2 个研究点 分布在 1 个国家目标入组 194 人开始时间: 2023年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
194
试验地点
2
主要终点
Change in Functional Outcomes of Sleep Questionnaire

研究概览

简要总结

This randomized controlled study will directly evaluate whether unattended polysomnography (level 2 sleep study) in individuals referred for sleep apnea or hypersomnia, including those with comorbidities of insomnia and sleep-related movement disorders, provides similar patient outcomes when compared to level 1 sleep studies.

详细描述

Individuals referred to the Sleep Disorder Centre with a major complaint of snoring or, apneas or hypersomnia, with at least one additional minor concern of snoring, apneas, restless leg syndrome or insomnia, will be considered for entry into the study. Using a randomized controlled trial design, study participants will be randomly assigned to either the intervention group who will undergo a full unattended polysomnography (level 2 home sleep study) using the Prodigy portable wireless sleep monitor or in-lab polysomnography (level 1 sleep study). Other aspects of care including the clinical assessment will be equivalent between groups. A randomly assigned sleep specialist physician will make treatment recommendations to the patient based on the sleep study results and determine the need for a subsequent testing (including repeat sleep studies) as part of each patient encounter. Physicians participating in the study will receive an introduction to the Odds Ratio Product (ORP) and training on its diagnostic potential. Diagnostic confidence using a 5 point Likert scale from 10% (very unsure) to 90% (very confident) will be assessed after each sleep study review.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • referral for major concern of "snoring" or "apnea" or "hypersomnia" with additional minor concerns of "snoring", "apneas" "restless leg syndrome" or "insomnia"
  • willing to undergo a sleep study

排除标准

  • referrals where parasomnias, respiratory failure, narcolepsy listed as concerns
  • comorbid congestive heart failure, ischemic heart disease, arrhythmia, stroke, chronic obstructive pulmonary disease/respiratory failure, patients with a BMI 50 kg/m2
  • undergone a previous sleep study

结局指标

主要结局

Change in Functional Outcomes of Sleep Questionnaire

时间窗: 4 months

Total Score scale ranges from 5-20, with higher scores representing better functioning

Rating of Physician Diagnostic Confidence

时间窗: within 4 weeks of sleep study, after patient assessment by physician

Likert scale rating performed by physicians to assess confidence in diagnosis from data provided by the two systems, scale from 1-5 with higher values reflecting greater confidence

Rating of Patient Satisfaction

时间窗: Measured in morning following their sleep study

Likert scale rating of patient satisfaction for their sleep study experience, ranges from 1-7 with higher values reflecting greater satisfaction

Continuous Positive Airway Pressure (CPAP) Adherence

时间窗: 4 months

Percent of nights with CPAP \> 4 hours/night

Cost between Level 1 and Level 2 tests based on equipment, facility, supply costs, and technician and physician service fees

时间窗: After study conclusion, an average of up to 1 year

Change in Calgary Sleep Apnea Quality of Life Index

时间窗: 4 months

Total score ranges from 1-7, with a greater score indicating a lower effect of OSA on quality of life

Change in Epworth Sleepiness Scale

时间窗: 4 months

Scale ranges from 0-24, with higher scores representing more sleepiness

次要结局

未报告次要终点

研究者

发起方
Cerebra Medical
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验